Groowe Groowe / Newsroom / NBIX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NBIX News

Neurocrine Biosciences Inc

Amplifica Appoints Hans Hofland, Ph.D., as Chief Development Officer and William Humphries to Board of Directors

prnewswire.com
ACRS ALC AMGN BCRX BIIB BMY CRSP CTRA CYTK DASH EXAS GILD GSK INCY JNJ KDP LULU MRNA NBIX NVS OCGN ORCL PFE REGN ROST RVMD SNOW SRPT STRL TGTX TMO TRMB TSLA TXG VRTX XOM ZBRA

Atsena Therapeutics Appoints Matt Pauls to Board of Directors

globenewswire.com
SVRA NBIX JNJ

Neurocrine Biosciences Announces Publication of KINECT-PRO™ Findings Demonstrating INGREZZA® (valbenazine) Capsules Improved Patient-Reported Quality of Life and Daily Functioning for People Living with Tardive Dyskinesia

prnewswire.com
NBIX

Global Neurodegenerative Disease Market is Expected to Showcase Significant Growth at a CAGR of ~6% by 2034 | DelveInsight

globenewswire.com
NVO LLY BMY AXSM JNJ SNY BIIB ABBV MRK REGN GILD AMGN AZN TEVA BHC ALKS VRTX SRPT CRIS NTLA EDIT INCY ACAD ALNY CYTK IONS EXAS IDXX VNDA SUPN RGNX XOM CVAC BNTX ARCT MRNA NBIX ADPT AVXL IMUX PRGS RDNT CRDF ADSK ANAB ATRC CLDX CPRX ESPR EXEL FGEN GALT GRFS HRMY IGC INSM KODK LAKE LCTX LEXX LPCN MESO MITK MNKD MSFT MYGN NEO NVCR NXPI OCGN OMER ORCL PACB PFE PLRX PRGO PSNL PTGX QGEN RARE ROST RVMD SEIC SIGA SMCI SNOW SOFI SPRO TGTX TNDM TXG ULTA VEEV VKTX VRNS WVE XRAY ZBRA ZNTL

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-'1968, a GLP-1/GIP/Glucagon Receptor Triple Agonist

prnewswire.com
NBIX

Form 8-K/A

sec.gov
NBIX

Form 8-K

sec.gov
NBIX

Neurocrine Biosciences Reports Second-Quarter 2026 Financial Results

prnewswire.com
NBIX

RARE Drug Development Symposium Marks 10th Anniversary with Dedicated Pitch Sessions and The Theme and Call to Action to Align Advocates, Science and Industry

prnewswire.com
BIIB REGN GILD BTE BROS BFLY BCTX BCRX BTAI ALRS CAPR CRIS CYCN EXAS FATE GNTX HRMY INCY IONS KODK LAKE LULU MRNA NBIX NTRA OCGN ORGN PGEN PLRX RARE RGNX RXRX SAVA SGMO SNOW SRPT STEM TGTX TLSA TXG VRTX ZETA

Neurocrine Biosciences Announces Key Leadership Hiring, Promotions

prnewswire.com
NBIX